]>
IRCT20200112046087N5 IRCT 2020-11-22 Traditional Medicine and Materia Medica Research Center The effect of compound “ma_ol_asal” syrup on oligomenorrhea in patients with polycystic ovary syndrome Effect of “ma_ol_asal” syrup on the treatment of Polycystic Ovarian Syndrome 2020-09-22 anticipated 20 Complete https://irct.ir/trial/51711 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. 2 Oligomenorrhoea. Intervention 1: . Intervention 2: Intervention group:. Yes - There is a plan to make this available What will be shared: The results of the studied items such as BMI, bleeding volume, menstrual period, etc. will be provided to the researchers. When: Start the access period at least one month after the results are published To whom: researchers Conditions: After the publication of the article extracted from the clinical trial, the said person will notify his / her request by email or contact. Where to obtain: Executor of the project, Ms. Dr. Mojgan Tanzaz tansaz_mojgan@yahoo.com Tel: 02188773525 How to obtain: After sending an email to Dr. Tan Saz, at his discretion and with the approval of the Vice Chancellor for Research, Shahid Beheshti School of Traditional Medicine, the required information will be provided. Comments:
public Hanieh Babaei
No. 8, Shams Alley, Vali-e Asr Ave, Tehran, Iran
Tehran Iran (Islamic Republic of) 1516745811 +98 21 8877 3521 haniehbabaei92@gmail.com Shahid Beheshti School of Traditional Medicine scientific Mojgan Tansaz
No. 8, Shams Alley, Vali-e Asr Ave, Tehran, Iran
Tehran Iran (Islamic Republic of) 1516745811 +98 21 8877 3521 tansaz_mojgan@sbmu.ac.ir Faculty of Traditional Medicine, Shahid Beheshti University Iran (Islamic Republic of) All women with PCO who present with an oligomenorrhea complaint and consent to the study 18 years 40 years Both People with any type of systemic disease such as diabetes, Cushing's, adrenal hyperplasia, hyperprolactin, hyper thyroidism Pregnant women and women who are breastfeeding (the first 6 months) are either planning to become pregnant or women who have had an abortion People taking hormonal medications, including LD pills People with a history of breast and ovarian cancer and people undergoing chemotherapy N91.4 Secondary Oligomenorrhoea Treatment - Drugs Intervention group: The effect of “ma_ol_asal”syrup on the duration of bleeding in patients with polycystic ovary syndrome. Timepoint: Before entering the study and after the treatment period. Method of measurement: Question from the patient. The effect of “ma_ol_asal” syrup on bleeding rate in patients with polycystic ovary syndrome. Timepoint: Before entering the study and after the treatment period. Method of measurement: Pictorial Bleeding Assessment Chart (PBAC). The effect of “ma_ol_asal” syrup on BMI in patients with polycystic ovary syndrome. Timepoint: Before entering the study and after the treatment period. Method of measurement: Meters and scales and BMI formula. Menstrual period. Timepoint: Before entering the study and after the treatment period. Method of measurement: Question from the patient. Cleanliness period. Timepoint: Before entering the study and after the treatment period. Method of measurement: Question from the patient. Traditional Medicine and Materia Medica Research Center Approved Approved 2020-10-12 Ethics committee of Shahid Beheshti University of Medical Sciences Shahid Beheshti University of Medical sciences, Daneshju Blv. Tehran Tehran Iran (Islamic Republic of)